SCHEMBL28806427

SCHEMBL28806427

C=CC(c1cccc(C(C)(C)C)c1)S(=O)(=O)n1c(C(CC)C(=O)O)cc2cc(C(F)(F)F)ccc21

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ PPARG P37231 15/20 0.36
▸ PPARA Q07869 10/20 0.36
▸ PPARD Q03181 6/20 0.36
▸ KCNQ2 O43526 2/20 0.35
▸ AKR1C3 P42330 1/20 0.32
▸ AKR1C2 P52895 1/20 0.32
▸ PTGFR P43088 1/20 0.32
▸ KCNQ3 O43525 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27909997 0.93 PPARG (0.35) MEN1ALDH1A1CYP1A2POLBCYP3A4
SCHEMBL27833814 0.91 PPARG (0.37) MEN1ALDH1A1CYP1A2POLBCYP3A4
SCHEMBL27813772 0.90 PPARG (0.36) MEN1ALDH1A1CYP1A2POLBCYP3A4
SCHEMBL27833813 0.84 PPARG (0.36) MEN1ALDH1A1CYP1A2POLBCYP3A4
SCHEMBL27950235 0.83 RXRA (0.34) MEN1KMT2APPARGPPARAPPARD
SCHEMBL27713774 0.81 ALDH1A1 (0.34) ALDH1A1PPARGPPARAPPARDAKR1C3
SCHEMBL28775099 0.81 PPARG (0.43) MEN1POLBKMT2APPARGPPARA
SCHEMBL28775106 0.81 TRPV1 (0.34) PPARGPPARAPPARDAKR1C3AKR1C2
SCHEMBL27713509 0.81 AKR1B1 (0.36) POLBSMN1; SMN2PPARGPPARAPPARD
SCHEMBL27713592 0.81 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102112441-B Use of indole derivatives as NURR-1 activators for the treatment of parkinson's disease FOURNIER LAB S A 2013-07-10 — — CN disclosed
Send feedback